Stock Price
0.69
Daily Change
-0.02 -2.13%
Monthly
50.00%
Yearly
634.04%
Q2 Forecast
0.71

Starpharma Holdings reported AUD-736K in Gross Profit on Sales for its fiscal semester ending in June of 2025.





Gross Profit On Sales Change Date
Medical Developments International AUD 7.35M 7.37M Jun/2025
Mesoblast USD 3.16M 9.61M Dec/2024
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025